Feasibility study comparing docetaxel-cisplatin versus docetaxel-carboplatin as first-line chemotherapy for ovarian cancer Stage at diagnosis Stage I - 38% (n = 6) Stage II - 19% (n = 3) Stage III - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback